Topic 356: fluorogenic assay platform for circular RNA detection
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91019C00046
- Awardee
-
Lucerna Inc. UEI J3MWGA6WFCG3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,480,983
Award facts
- Contract value 100% obligated
- $1,480,983.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Brooklyn, NY 11226, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,480,983 |
About this award
The National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, awarded a $1,480,983.00 Firm Fixed Price contract to Lucerna Inc., a minority-owned and self-certified small disadvantaged business. The contract, set aside for small businesses, is for the development of a fluorogenic assay platform to detect circular RNA biomarkers related to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. This contract aligns with NCI's research priorities in addressing "undruggable" protein targets underlying various diseases. Lucerna Inc. has previously received other prime federal contracts and grants from HHS agencies, including the National Institutes of Health, to develop cell-based assays and sensors for detecting and modulating RNA biomarkers in neurodegenerative diseases and cancer.
Quick answers
Who was awarded contract 75N91019C00046?
75N91019C00046 was awarded to Lucerna Inc. by National Cancer Institute (National Institutes of Health) on September 16, 2019.
How much is contract 75N91019C00046 worth?
The government has obligated $1,480,983 on 75N91019C00046.
Was contract 75N91019C00046 competed?
The extent of competition for 75N91019C00046 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award